BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22999893)

  • 21. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.
    Tohen M; Chengappa KN; Suppes T; Baker RW; Zarate CA; Bowden CL; Sachs GS; Kupfer DJ; Ghaemi SN; Feldman PD; Risser RC; Evans AR; Calabrese JR
    Br J Psychiatry; 2004 Apr; 184():337-45. PubMed ID: 15056579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintenance therapy with second generation antipsychotics for bipolar disorder - A systematic review and meta-analysis.
    Lindström L; Lindström E; Nilsson M; Höistad M
    J Affect Disord; 2017 Apr; 213():138-150. PubMed ID: 28222360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.
    Vieta E; T'joen C; McQuade RD; Carson WH; Marcus RN; Sanchez R; Owen R; Nameche L
    Am J Psychiatry; 2008 Oct; 165(10):1316-25. PubMed ID: 18381903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation into the long-term metabolic effects of aripiprazole adjunctive to lithium, valproate, or lamotrigine.
    Kemp DE; De Hert M; Rahman Z; Fyans P; Eudicone JM; Marler SV; Baker RA; Carlson BX
    J Affect Disord; 2013 May; 148(1):84-91. PubMed ID: 23261129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outpatients with bipolar I depression: did baseline characteristics impact trial outcome?
    Lombardo I; Sachs G; Kolluri S; Kremer C; Yang R
    J Clin Psychopharmacol; 2012 Aug; 32(4):470-8. PubMed ID: 22722504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.
    ; Geddes JR; Goodwin GM; Rendell J; Azorin JM; Cipriani A; Ostacher MJ; Morriss R; Alder N; Juszczak E
    Lancet; 2010 Jan; 375(9712):385-95. PubMed ID: 20092882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.
    Keck PE; Versiani M; Potkin S; West SA; Giller E; Ice K;
    Am J Psychiatry; 2003 Apr; 160(4):741-8. PubMed ID: 12668364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maintenance efficacy of divalproex in the prevention of bipolar depression.
    Gyulai L; Bowden CL; McElroy SL; Calabrese JR; Petty F; Swann AC; Chou JC; Wassef A; Risch CS; Hirschfeld RM; Nemeroff CB; Keck PE; Evans DL; Wozniak PJ
    Neuropsychopharmacology; 2003 Jul; 28(7):1374-82. PubMed ID: 12784116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics.
    Woo YS; Bahk WM; Jung YE; Jeong JH; Lee HB; Won SH; Lee KH; Jon DI; Yoon BH; Kim MD; Min KJ
    Psychiatry Clin Neurosci; 2014 Jun; 68(6):418-24. PubMed ID: 24506520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ziprasidone in bipolar disorder.
    Versiani M
    Expert Opin Pharmacother; 2006 Jun; 7(9):1221-8. PubMed ID: 16732708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently.
    Macfadden W; Alphs L; Haskins JT; Turner N; Turkoz I; Bossie C; Kujawa M; Mahmoud R
    Bipolar Disord; 2009 Dec; 11(8):827-39. PubMed ID: 19922552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines.
    Verdolini N; Hidalgo-Mazzei D; Murru A; Pacchiarotti I; Samalin L; Young AH; Vieta E; Carvalho AF
    Acta Psychiatr Scand; 2018 Sep; 138(3):196-222. PubMed ID: 29756288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
    Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
    Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study).
    Weisler RH; Nolen WA; Neijber A; Hellqvist A; Paulsson B;
    J Clin Psychiatry; 2011 Nov; 72(11):1452-64. PubMed ID: 22054050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state.
    Patkar A; Gilmer W; Pae CU; Vöhringer PA; Ziffra M; Pirok E; Mulligan M; Filkowski MM; Whitham EA; Holtzman NS; Thommi SB; Logvinenko T; Loebel A; Masand P; Ghaemi SN
    PLoS One; 2012; 7(4):e34757. PubMed ID: 22545088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder.
    Warrington L; Lombardo I; Loebel A; Ice K
    CNS Drugs; 2007; 21(10):835-49. PubMed ID: 17850172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ziprasidone for maintenance treatment of bipolar I disorder in adults.
    Dubovsky SL; Dubovsky AN
    Expert Opin Pharmacother; 2011 Apr; 12(5):817-24. PubMed ID: 21385150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y; Kim E; You M; Pikalov A; Tran QV
    J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.